Rifampicin Production Cost Analysis 2020

Rifampicin, which is also known as rifampin, is an antibiotic that is uitlised to treat numerous kinds of bacterial infections, like tuberculosis, mycobacterium avium complex, leprosy, and legionnaires’ disease. Rifampicin is created by the soil bacterium Amycolatopsis rifamycin. It is almost always used along with other antibiotics, except while it is given to prevent Haemophilus influenzae type B or meningococcal disease in people who have been exposed to those bacteria. Rifampicin may be given either orally or intravenously.

Rifampicin belongs to the rifamycin group of antibiotics. It works by blocking the production of RNA by bacteria. It was discovered in 1965, marketed in Italy in 1968, and finally approved in the United States in 1971. It is on the WHO’s List of Essential Medicines, which are the safest, as well as the most effective medicines required in a healthcare system. It is available as a generic medication.

Procurement Resource provides an in-depth cost analysis of Rifampicin production. The report incorporates the manufacturing process with detailed process and material flow, capital investment, operating costs along with financial expenses and depreciation charges. The study is based on the latest prices and other economic data available. We also offer additional analysis of the report with detailed breakdown of all cost components (Capital Investment Details, Production Cost Details, Economics for another Plant Location, Dynamic Cost Model).

Reports

Rifampicin Production from Mixed Carbon Source
  • Rifampicin Production from Mixed Carbon Source

    This report presents the economics of rifampicin production from mixed carbon sources (peanut meal, soybean flour, glucose, and starch) via a typical fermentation process.

    Analysis Basis: Germany

    Period of Analysis: Q3 2020

    Starting at USD 1799


Related Reports

Tanespimycin Production from Corn
  • Tanespimycin Production from Corn

    This report presents an up-to-date, detailed cost analysis of Tanespimycin production from corn. The process examined is a typical fermentation process.

    Analysis Basis: Germany

    Period of Analysis: Q3 2020

    Starting at USD 1799


Lactoflavin Production from Fermentation Process

Cefalotin Production via Crystallisation
  • Cefalotin Production via Crystallisation

    This report presents a detailed cost analysis of cefalotin production from 2-TAC and 7-ACA using the crystallisation process.

    Analysis Basis: Germany

    Period of Analysis: Q3 2020

    Starting at USD 1799


Procurement Resource

Supply Demand and Market Analysis


Feasibility Studies


Techno-economic Evaluations


Investment Analysis


Multi-regional Cost Analyses

Evaluate Other Plant Locations

This report presents an analysis of capital and operating costs of a -based industrial plant. For those interested in economic assessments considering other plant locations, Procurement Resource offers optional analyses that complement this report.